Publications by authors named "Lise Wind-Hansen"
Article Synopsis
- This study assesses the effectiveness of targeted drug treatments for chronic lymphocytic leukaemia (CLL) in a Danish cohort, comparing them to traditional chemotherapy.
- Results show that patients receiving targeted treatments, like ibrutinib and venetoclax, had a significantly better treatment-free survival (TFS) and overall survival (OS) compared to those on older chemotherapy regimens.
- Adverse events (AEs) were common in all treatment groups, but targeted therapies had a higher incidence of severe AEs, indicating the need for careful patient management.
